Drug level in mouse plasma treated with (S)-2-((3R,6R,9S,12R)-3,9-dibenzyl-6,12-bis((1-butyl-1H-indol-3-yl)methyl)-4,7,10-trioxo-2,5,8,11-tetraazatrid...

Basic Information

ID: ALA4139823

Type: ADME

Description: Drug level in mouse plasma treated with (S)-2-((3R,6R,9S,12R)-3,9-dibenzyl-6,12-bis((1-butyl-1H-indol-3-yl)methyl)-4,7,10-trioxo-2,5,8,11-tetraazatridecanamido)-4-methylpentanamide at 400 ug/ml after 3 to 48 hrs by RP-HPLC method

Format: BAO_0000366

Organism: Mus musculus

Tissue: Plasma

Target: ADMET(ALA612558)

Document: ALA4138117

Drug level in mouse plasma treated with (S)-2-((3R,6R,9S,12R)-3,9-dibenzyl-6,12-bis((1-butyl-1H-indol-3-yl)methyl)-4,7,10-trioxo-2,5,8,11-tetraazatridecanamido)-4-methylpentanamide at 400 ug/ml after 3 to 48 hrs by RP-HPLC method: 1

Associated Items: Associated Bioactivities Associated Compounds

Activity Charts

Bioactivity

Activity Types for Assay ALA4139823

Drug metabolism

Total(1)

Parent Molecular Weight	ALogP	Polar Surface Area
868.09	5.85	5.85

Parent Molecular Weight

ALogP

Polar Surface Area

868.09

5.85

Drug level in mouse plasma treated with (S)-2-((3R,6R,9S,12R)-3,9-dibenzyl-6,12-bis((1-butyl-1H-indol-3-yl)methyl)-4,7,10-trioxo-2,5,8,11-tetraazatrid...

Basic Information

Activity Charts

Compound Summary